SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-21-012329
Filing Date
2021-11-26
Accepted
2021-11-26 17:15:20
Documents
1
Period of Report
2021-11-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-54401.html 4  
1 PRIMARY DOCUMENT marketforms-54401.xml 4 4732
  Complete submission text file 0001214659-21-012329.txt   6494
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451 6174982850
Jordan Edward P. (Reporting) CIK: 0001600814 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 211452255